Hypha Labs (FUNI) Price to Sales (2012 - 2024)

Hypha Labs (FUNI) has reported Price to Sales for 13 consecutive years, with 2.96 the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Price to Sales rose 173.3% year-over-year to 2.96; the trailing twelve-month figure through Sep 2024 stood at 1.86 (up 611.01% YoY), and the FY2024 full-year result was 1.86, up 611.01% from the prior year.
• Price to Sales retreated to 2.96 in Q1 2024 per FUNI's latest filing, from 3.77 in the prior quarter.
• Across five years, Price to Sales topped out at 5.66 in Q2 2020 and bottomed at 0.82 in Q3 2023.
• Historically, Price to Sales has averaged 2.86 across 5 years, with a median of 2.56 in 2020.
• The sharpest annual moves came in 2020 and 2023: Price to Sales sank 77.99% in 2020, then jumped 233.27% in 2023.
• Over 5 years, Price to Sales stood at 2.56 in 2020, then advanced by 21.8% to 3.12 in 2021, then plunged by 63.69% to 1.13 in 2022, then surged by 233.27% to 3.77 in 2023, then decreased by 21.65% to 2.96 in 2024.
• According to Business Quant data, Price to Sales over the past three periods registered 2.96, 3.77, and 0.82 for Q1 2024, Q4 2023, and Q3 2023 respectively.